PHARMACEUTICAL OPPORTUNITIES
Pharmaceutical Opportunities
![](https://medicalcompaniesforsale.com/wp-content/uploads/2023/06/softgel_image.png)
Tech–2573: GMP-FDA Nutraceutical Manufacturer in Mountain West
GMP-certified, and FDA-registered manufacturer can handle large and small batch production of Nutraceutical and CBD softgels, gummies and tinctures. Revenue about $1M, Assets, worth $1M, Price: $2.95M
![](https://medicalcompaniesforsale.com/wp-content/uploads/2019/05/antibody_protein.jpg)
Tech-9094c: Licensing Opportunity: RNA Inhibitors for Cancer Treatment
This technology, offered for licensing, provides a novel and potentially non-toxic approach to treat a wide range of cancers using RNA Inhibitors.
![](https://medicalcompaniesforsale.com/wp-content/uploads/2018/12/pharma-3.jpg)
Tech-9094b: Versatile PEG Nanoparticles for Drug Delivery
These biocompatible, non-toxic nanospheres are 20-80 nm in size and due to their hydrophilc-hydrophobic nature, are ideally suited for encapsulating drugs.
![](https://medicalcompaniesforsale.com/wp-content/uploads/2018/11/pseudomonas_aeruginosa-e1666957773659.png)
Tech-9094a: Antibiotic Drug Candidate for Licensing
This peptide-based drug candidate has a broad range of antimicrobial activity and specific capabilities to fight Pseudomonas aeruginosa. Safe with low toxicity. Can envision this to be an effective anti-sepsis drug.